|
|
Analysis of risk factors for early seizures after endovascular therapy for acute ischemic stroke |
QIN Bailing LI Tong HU Minting WEI Chunyan#br# |
Department of Neurology, Nanning No.2 People’s Hospital, Guangxi Zhuang Autonomous Region, Nanning 530031, China
|
|
|
Abstract Objective To investigate the risk factors for early seizures after endovascular therapy for acute ischemic stroke. Methods A retrospective summary was made of 184 patients with acute ischemic stroke who underwent endovascular treatment in the Department of Neurology, Nanning Second People’s Hospital from June 2019 to December 2021. The patients were divided into 36 cases in the epilepsy group and 148 cases in the non-epileptic group according to whether they were complicated with epilepsy. Neurological deficits were assessed using the National Institutes of Health stroke scale (NIHSS) score, and the Glasgow coma scale (GCS) were used to assess the degree of disturbance of consciousness. Logistic regression was used to analyze the possible risk factors of early seizures after endovascular therapy for acute ischemic stroke. Results The proportion of epilepsy group in age ≤65 years old, preoperative NIHSS score>11 points, preoperative GCS≤8 points, diabetes, anterior circulation lesions, mechanical thrombectomy and aspiration, hemorrhagic transformation, and operation duration>1 h were higher than those of the non-epilepsy group (P < 0.05). The results of multivariate logistic regression analysis showed that the preoperative NIHSS score>11 points, preoperative GCS≤8 points, mechanical thrombectomy, hemorrhagic transformation and aspiration, operation time>1 h were independent risk factors for acute ischemic stroke complicated with early epilepsy after endovascular treatment (P < 0.05). Conclusion Disease severity, surgical method, hemorrhagic transformation and duration of surgery are risk factors for early seizures in patients undergoing endovascular interventional therapy in the acute phase, and it is worthy of clinical attention.
|
|
|
|
|
[1] Wang YJ,Li ZX,Gu HQ,et al. China Stroke Statistics 2019:A Report From the National Center for Healthcare Quality Management in Neurological Diseases,China National Clinical Research Center for Neurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations [J]. Stroke Vasc Neurol,2020,5(3):211-239.
[2] Silva GS,Nogueira RG. Endovascular Treatment of Acute Ischemic Stroke [J]. Continuum (Minneap Minn),2020, 26(2):310-331.
[3] Tanaka T,Ihara M. Post-stroke epilepsy [J]. Neurochem Int,2017,107:219-228.
[4] Runde D. Calculated Decisions:National Institutes of Health Stroke Scale (NIHSS) [J]. Emerg Med Pract,2019,21(Suppl 6):CD1-CD3.
[5] Z?觟llner JP,Misselwitz B,Kaps M,et al. National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke:a population-based study involving 135,117 cases [J]. Sci Rep,2020,10 (1):3779.
[6] Jain S,Iverson LM. Glasgow Coma Scale. In:StatPearls. Treasure Island (FL):StatPearls Publishing,June 20,2021.
[7] Fisher RS,Acevedo C,Arzimanoglou A,et al. ILAE offificial report:a practical clinical defifinition of epilepsy [J]. Epilepsia,2014,55(4):475-482.
[8] Yang H,Guo A,Wang Y,et al. The pathogenesis of post stoke seizure and epilepsy [J]. J Clin Neurol,2016,29:389-392.
[9] Yang H,Rajah G,Guo A,et al. Pathogenesis of epileptic seizures and epilepsy after stroke [J]. Neurol Res,2018, 40(6):426-432.
[10] Zelano J,Holtkamp M,Agarwal N,et al. How to diagnose and treat post-stroke seizures and epilepsy? [J]. Epileptic Disord,2020,22(3):252-263.
[11] Kanner AM,Mazarati A,Koepp M. Biomarkers of epileptogenesis:psychiatric comorbidties? [J]. Neurotherapeutics,2014,11(2):358-372.
[12] Grigolashvili MA,Zhuanysheva EM. Risk factors for post stroke epilepsy [J]. Zh Nevrol Psikhiatr Im S S Korsakova,2021,121(8.Vyp.2):35-40.
[13] Harnod T,Lin CL,Kao CH. Epilepsy is associated with higher subsequent mortality risk in patients after stroke:a population-based cohort study in Taiwan [J]. Clin Epidemiol,2019,11:247-255.
[14] Giles JA,Vellimana AK,Adeoye OM. Endovascular Treatment of Acute Stroke [J]. Curr Neurol Neurosci Rep,2022,22(1):83-91.
[15] Ferreira-Atuesta C,D?觟hler N,Erdélyi-Canavese B,et al. Seizures after Ischemic Stroke:A Matched Multicenter Study [J]. Ann Neurol,2021,90(5):808-820.
[16] Thevathasan A,Naylor J,Churilov L,et al. Association between hemorrhagic transformation after endovascular therapy and poststroke seizures [J]. Epilepsia,2018,59(2):403-409.
[17] Gasparini S,Ascoli M,Brigo F,et al. Younger age at stroke onset but not thrombolytic treatment predicts poststroke epilepsy:An updated meta-analysis [J]. Epilepsy Behav,2020,104(Pt B):106540.
[18] Galovic M,Ferreira-Atuesta C,Abraira L,et al. Seizures and Epilepsy After Stroke:Epidemiology,Biomarkers and Management [J]. Drugs Aging,2021,38(4):285-299.
[19] Eriksson H,L?觟whagen Hendén P,Rentzos A,et al. Acute symptomatic seizures and epilepsy after mechanical thro-mbectomy [J]. Epilepsy Behav,2020,104(Pt B):106520.
[20] 中国卒中学会,中国卒中学会神经介入分会,中华预防医学会,等.急性缺血性卒中血管内治疗中国指南2018[J].中国卒中杂志,2018,13(7):706-729.
[21] Delgado MG,Bogousslavsky J. Cerebral Hyperperfusion Syndrome and Related Conditions [J]. Eur Neurol,2020, 83(5):453-457.
[22] Baracchini C,Farina F,Palmieri A,et al. Early hemodynamic predictors of good outcome and reperfusion injury after endovascular treatment [J]. Neurology,2019,92(24):e2774-e2783.
[23] Onishi S,Sakamoto S,Okazaki T,et al. Iodinated Contrast Encephalopathy after Coil Embolization of Unruptured Aneurysms [J]. Asian J Neurosurg,2018,13(3):858-860.
[24] Babalova L,Ruzinak R,Ballova J,et al. Contrast-induced encephalopathy [J]. Bratisl Lek Listy,2021,122(9):618-620.
[25] Chu YT,Lee KP,Chen CH,et al. Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke [J]. Stroke,2020,51(12):3756-3759.
[26] Chen K,Obaid S,Guillon-Létourneau L,et al. Iodinated Contrast Encephalopathy [J]. Can J Neurol Sci,2017,44(4):432-433. |
|
|
|